FeesSafety
Pluang+

Homeowners in Central NY urged to prevent roof collapse from heavy snow and ice this winter.

Others
02 Nov 2026, 21:34 WIB
PRNewsWire
View Source
Neutral
Homeowners in Central NY urged to prevent roof collapse from heavy snow and ice this winter.

Homeowners in Central New York are advised to take proactive steps to prevent roof collapse due to heavy snow and ice this winter. Key measures include understanding snow load differences, maintaining good attic insulation and ventilation to prevent ice dams, keeping gutters clean, and scheduling professional roof inspections before winter. Experts warn that ignoring early signs like sagging rafters or leaks can lead to costly damage, while regular maintenance and possible structural reinforcements can extend roof life and safety. Prevention is emphasized as more cost-effective than repairs after damage occurs.

The roofing expert Michael Majeski's advice on snow and ice load impacts provides context for readers interested in related sectors. For readers following Industrials, here is Pluang's market snapshot as of Nov 03, 2026 02:41 WIB: out of 135 priced US Industrials stocks, 88 rose and 47 fell. Notable movers include LUNR at USD 10.00 with a 1-day change of -6.28% and 100% sell order activity, RKLB at USD 51.39 with a -6.10% change and a typical hold time of 33 days, and CPRT at USD 31.92 with a +5.98% change and a typical hold time of 3 days.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
1 hour ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
3 hours ago
FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

The FDA placed Bright Minds Biosciences' planned Phase 2 epilepsy trial for BMB-101 on partial clinical hold due to toxicity findings in mice and insufficient pharmacokinetic and juvenile-toxicity data. This action caused a sharp decline in the compa...

Market News
Bearish
5 hours ago
NEAR governance cuts max annual token issuance from 2.5% to 1.6%, lowering staking rewards.

NEAR governance cuts max annual token issuance from 2.5% to 1.6%, lowering staking rewards.

NEAR governance approved a plan to reduce the maximum annual issuance of the NEAR token from 2.5% to 1.6%. This change aims to slow the rate at which new tokens enter circulation, potentially impacting staking rewards by lowering them. The plan inclu...

Protocol Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App